Oxford House Residents’ Attitudes Toward Medication Assisted Treatment Use in Fellow Residents
Methadone and buprenorphine/naloxone are medication assisted treatment (MAT) options for treating opioid use disorder, yet attitudes regarding their use within abstinence-based recovery homes have not been assessed. The present investigation examined attitudes regarding MAT utilization among residents living in Oxford Houses. This cross-sectional investigation compared residents (n = 87) receiving MAT whose recent drug use involved opioids, and two groups not receiving MATs; those who had used opioids and those who had used substances other than opioids. The vast majority of residents were not receiving MAT, yet 32% reported MAT histories. Negative attitudes regarding MAT were observed among residents who were not receiving MAT. Those presently receiving MAT reported mixed attitudes regarding the use of methadone and buprenorphine/naloxone, and two of these residents reported they had never been prescribed MAT. Findings suggest that abstinence-based recovery homes such as Oxford Houses may not be optimal resources for persons receiving MATs. © 2018 Springer Science+Business Media, LLC, part of Springer Nature
Community Mental Health Journal
pre print, post print (with 12 month embargo)
Majer, J.M.; Beasley, C.; Stecker, E.; Bobak, T.J.; Norris, J.; Nguyen, H.M.; Ogata, M.; Siegel, J.; Isler, B.; Wiedbusch, E.; and Jason, L.A., "Oxford House Residents’ Attitudes Toward Medication Assisted Treatment Use in Fellow Residents" (2018). SIAS Faculty Publications. 860.